Safety And Effectiveness Of NaviFUS System With Bevacizumab In Recurrent Glioblastoma
Safety And Effectiveness Of NaviFUS System With Bevacizumab In Recurrent Glioblastoma
Not yet recruiting · NCT07274787 · Registry updated 2026-06-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety And Effectiveness Of NaviFUS System With Bevacizumab In Recurrent Glioblastoma | glioblastoma | Not yet recruiting | Not applicable | 2026-06-04 | NCT07274787 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| NaviFUS Corporation | 7 |
| University of Cincinnati | 87 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of Cincinnati Medical Center | Cincinnati | United States | 83 |